Suraksha Diagnostic is a leading provider of clinical testing, diagnostic services, and medical consultations. As of March 31, 2024, the company operates through a robust network that includes a central reference laboratory, eight satellite laboratories, and 194 customer touchpoints. These touchpoints comprise 48 diagnostic centres and 146 primarily franchised sample collection centres, strategically located across West Bengal, Bihar, Assam, and Meghalaya. The central reference laboratory holds accreditation from the College of American Pathologists, ensuring adherence to the highest quality standards.

The company offers a comprehensive portfolio of over 2,300 tests. Its diagnostic offerings include 788 routine pathology tests, such as basic biochemistry and haematology, and 647 specialized tests, encompassing advanced biochemistry, histopathology, and molecular pathology. In the field of radiology, the test menu features 748 basic and intermediate services, including X-rays, ultrasonography (USG), and CT scans, as well as 104 advanced radiology tests, like MRI and specialized CT scans. The company is equipped with 24 CT machines and 13 MRI machines to support these services.

Between FY 2022 and FY 2024, Suraksha Diagnostic achieved a revenue growth rate of 20.87% CAGR. By the end of March 2024, 43 diagnostic centres included 120 polyclinic chambers, which hosted over 750 specialist doctors, offering patients a convenient healthcare experience. The organization also employed 1,522 permanent staff members as of the same date.